[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"laparoscopic-sleeve-gastrectomy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:laparoscopic-sleeve-gastrectomy":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,5,0,[8,53,81,106,134],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":31,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":52},"100643754","eating-behavior-nutritional-status-and-appetite-hormones-after-bariatric-surgery-100643754",false,"NCT07636239","Eating Behavior, Nutritional Status and Appetite Hormones After Bariatric Surgery","Evaluation of Changes in Postoperative Eating Behavior Attitudes, Nutritional Status, and Some Hormonal Parameters Regulating Appetite in Surgical Weight Management","BCKYL-YDB","Inclusion Criteria:\n\n* Having undergone Laparoscopic Sleeve Gastrectomy (LSG) within the last month\n* Aged between 18-50 years\n* Signing the informed consent form\n* Having a Body Mass Index (BMI) of 40 kg\u002Fm2 or between 35-40 kg\u002Fm2 with obesity-related comorbidities\n* No diagnosis of depression\n* No eating behavior disorder\n* No psychiatric disorder\n\nExclusion Criteria:\n\n* Not having undergone Laparoscopic Sleeve Gastrectomy (LSG) or not planning to undergo bariatric surgery\n* Not being in the age range of 18-50 years\n* Not signing the informed consent form\n* Having a Body Mass Index (BMI) greater than 40 kg\u002Fm2 or less than 35 kg\u002Fm2 without obesity-related comorbidities\n* Having a diagnosis of depression\n* Having an eating behavior disorder\n* Having a psychiatric disorder","ALL","18 Years","50 Years",{"count":21,"type":22},40,"ESTIMATED","OBSERVATIONAL","This study aims to evaluate changes in eating behavior attitudes, nutritional status, and appetite-regulating hormonal parameters in individuals who have undergone Laparoscopic Sleeve Gastrectomy (LSG). The study will be conducted at Bursa Yıldırım Doruk Hospital, Department of General Surgery. A total of 40 volunteer participants who underwent LSG within the last month will be included. Participants will be assessed at baseline (shortly after surgery) and at 6-month follow-up. Assessments will include anthropometric measurements (body weight, height, waist and hip circumference, BMI, waist-to-hip ratio), 3-day dietary intake records analyzed using BeBIS 8.2 software, and the Adult Eating Behavior Scale. Biochemical parameters including fasting blood glucose, total cholesterol, triglycerides, HDL, LDL, VLDL cholesterol, and insulin will be obtained from patient files and analyzed using Advia Chemistry 2400 and Advia XPT devices. Additionally, appetite-regulating hormones (ghrelin, GLP-1, PYY) will be analyzed from residual blood samples using the ELISA method with RelAssay Diagnostics kits by Teknogen Bioengineering Laboratory. All data will be compared between baseline and 6-month follow-up to evaluate the impact of bariatric surgery on nutritional and hormonal outcomes.",[26,27,28,29,30],"Obesity","Bariatric Surgery","Laparoscopic Sleeve Gastrectomy","Eating Behavior","Nutritional Status",[26,27,28,29,32,33,34,35,36,37,38,39],"Nutritional status","Ghrelin","GLP-1","Peptite YY","Appetite hormones","Body mass index","Weight loss","Dietary intake","NOT_YET_RECRUITING","2026-06-02",{"date":43,"type":44},"2026-06-09","ACTUAL",{"date":46,"type":22},"2026-07-01",{"date":48,"type":22},"2027-02-01",{"name":50,"class":51},"Özlem ÖZPAK AKKUŞ","OTHER",1,{"id":54,"slug":55,"hasResults":11,"nctId":56,"briefTitle":57,"officialTitle":57,"acronym":4,"eligibilityCriteria":58,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":59,"enrollmentInfo":60,"targetDuration":4,"studyType":62,"phases":63,"briefSummary":65,"conditions":66,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":52},"100621093","ultrasound-guided-external-oblique-intercostal-plane-block-versus-subcostal-transversus-abdominis-plane-block-for-perioperative-analgesia-in-laparoscopic-sleeve-gastrectomy-100621093","NCT07366138","Ultrasound-Guided External Oblique Intercostal Plane Block Versus Subcostal Transversus Abdominis Plane Block For Perioperative Analgesia in Laparoscopic Sleeve Gastrectomy","Inclusion Criteria:\n\n* Age from 18 to 65 years.\n* Both genders.\n* American Society of Anesthesiologists (ASA) class I or II\n* Body mass index (BMI) between 30-50 kg\u002Fm².\n* Scheduled for elective laparoscopic sleeve gastrectomy under general anesthesia.\n* Written informed consent from patients or surrogate decision makers.\n\nExclusion Criteria:\n\n* Patient refusal.\n* Allergy to local anesthetics.\n* Coagulation disorders or anticoagulant therapy.\n* Local infection or scar at the injection site.\n* Severe hepatic or renal dysfunction.\n* Chronic opioid use or psychiatric illness interfering with pain assessment.\n* Conversion to open surgery or intraoperative complications requiring re-exploration.","65 Years",{"count":61,"type":22},70,"INTERVENTIONAL",[64],"NA","This study aims to compare the analgesic efficacy, duration of analgesia, and overall opioid consumption between the external oblique intercostal plane (EOIP) block and subcostal transversus abdominis plane (TAP) block in patients undergoing laparoscopic sleeve gastrectomy.",[67,68,69,70,28],"Ultrasound","External Oblique Intercostal Plane Block","Subcostal Transversus Abdominis Plane Block","Perioperative Analgesia","RECRUITING","2026-01-17",{"date":74,"type":44},"2026-01-26",{"date":76,"type":44},"2025-11-01",{"date":78,"type":22},"2026-11-01",{"name":80,"class":51},"Benha University",{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":4,"eligibilityCriteria":87,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":59,"enrollmentInfo":88,"targetDuration":4,"studyType":62,"phases":90,"briefSummary":91,"conditions":92,"keywords":94,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":52},"100555715","modified-thoracoabdominal-nerve-plane-block-in-laparoscopic-sleeve-gastrectomy-100555715","NCT06515691","Modified Thoracoabdominal Nerve Plane Block In Laparoscopic Sleeve Gastrectomy","Evaluation of Effectiveness of Ultrasound-Guided Modified Thoracoabdominal Nerve Plane Block Through Perichondrial Approach (M-TAPA) for Postoperative Analgesia Management in Patients Undergoing Laparoscopic Sleeve Gastrectomy Operation","Inclusion Criteria: American Society of Anesthesiologists (ASA) classification II- III Patients Scheduled for LSG under general anesthesia\n\n\\-\n\nExclusion Criteria: Patients\n\n* with a history of bleeding diathesis,\n* receiving anticoagulant treatment,\n* with allergies or sensitivity to drugs used,\n* with an infection on the puncture site\n* with a history of alcohol or drug addiction,\n* with congestive heart failure\n* with liver or kidney disease\n* who do not accept the procedure or participate in the study",{"count":89,"type":22},60,[64],"Ultrasound-guided Modified Thoracoabdominal Nerve Plane Block (M-TAPA) is performed into the costochondral aspect at the 9th-10th costal level by injecting local anesthetics deep into the chondrium. It provides blockage of both the anterior and lateral cutaneous branches of the thoracoabdominal nerve. Studies show that M-TAPA block is effective for postoperative analgesia and other abdominal surgeries, but its effect on patients undergoing LSG surgery has not yet been studied. The hypothesis is that the M-TAPA block performed in patients undergoing Laparoscopic Sleeve Gastrectomy (LSG) Operation would reduce opioid consumption in the first 24 hours period after surgery.",[26,27,28,93],"Acute Post Operative Pain",[95,28,27,96],"ModifiedThoracoabdominal Nerve Plane Block","Acute Postoperative Pain","2025-12-18",{"date":99,"type":44},"2025-12-24",{"date":101,"type":44},"2025-01-03",{"date":103,"type":22},"2026-02-15",{"name":105,"class":51},"Istanbul Medipol University Hospital",{"id":107,"slug":108,"hasResults":11,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":112,"eligibilityCriteria":113,"healthyVolunteers":114,"sex":17,"minAge":18,"maxAge":115,"enrollmentInfo":116,"targetDuration":4,"studyType":62,"phases":118,"briefSummary":119,"conditions":120,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":125,"lastUpdatePostDateStruct":126,"startDateStruct":128,"completionDateStruct":130,"leadSponsor":132,"locationsCount":52},"100548747","effects-of-assisted-robotic-vs-laparoscopic-sleeve-gastrectomy-100548747","NCT06425016","Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy","Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy (EARLY): A Randomized Controlled Trial on Early Postoperative Pain","EARLY","Inclusion Criteria:\n\n* All patients eligible to undergo a SG based on the current National Institute of Health (NIH) patient selection guidelines. Patients should be able to give consent, be deemed medically cleared to undergo elective surgery, and tolerate general anesthesia.\n\nExclusion Criteria:\n\n* patients with previous bariatric surgeries, emergency surgeries, with chronic opioid use (daily use of opioids for at least 3 months), and those who are not able to sign the written consent form.",true,"70 Years",{"count":117,"type":22},91,[64],"This will be a prospective, obesity-registry based, single-blind randomized controlled trial with a 1:1 allocation ratio. Specific inclusion criteria are all patients eligible to undergo a Laparoscopic sleeve gastrectomy (LSG) based on the current National Institute of Health (NIH) patient selection guidelines. Patients should be able to give consent, be deemed medically-cleared to undergo elective surgery, and tolerate general anesthesia. All enrollments and surgeries in this study will take place at the Cleveland Clinic Bariatric and Metabolic Institute. The study will consist of 2 interventions: laparoscopic sleeve gastrectomy (LSG) or robotic sleeve gastrectomy (RSG). The primary objective is early postoperative pain, but also surgeon ergonomics and patient quality of life will be compared. Additional outcomes include 30-day perioperative results, minor and major morbidities, serious adverse events, resolution of medical comorbidities, and weight loss in percent of excess weight lost (%EWL) at one year.",[121,28,122,26,123,124],"Post Operative Pain","Robotic Sleeve Gastrectomy","Bariatric Surgery Candidate","Quality of Life","2025-12-03",{"date":127,"type":44},"2025-12-10",{"date":129,"type":44},"2024-07-17",{"date":131,"type":22},"2027-04-30",{"name":133,"class":51},"Ricard Corcelles",{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":138,"acronym":4,"eligibilityCriteria":139,"healthyVolunteers":11,"sex":17,"minAge":140,"maxAge":141,"enrollmentInfo":142,"targetDuration":4,"studyType":62,"phases":143,"briefSummary":146,"conditions":147,"keywords":148,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":153,"lastUpdatePostDateStruct":154,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":52},"100590684","phase-2-quality-of-recovery-in-laparoscopic-sleeve-gastrectomy-using-dexmedetomidine-infusion-versus-laparoscopic-tap-block-in-combination-with-paragastric-neural-block-100590684","NCT06970626","Quality of Recovery in Laparoscopic Sleeve Gastrectomy Using Dexmedetomidine Infusion Versus Laparoscopic TAP Block in Combination With Paragastric Neural Block","Inclusion Criteria:\n\n1. American Society of Anesthesiologists (ASA) physical status II- III\n2. BMI 35- 50 kg\u002Fm2\n\nExclusion Criteria:\n\n1. Significant hepatic, renal, neuromuscular, or cardiac impairments\n2. Extreme obesity (BMI \\> 50 kg\u002Fm2)\n3. Patients on current opioid medication\n4. Allergies to dexmedetomidine or bupivacaine","20 Years","60 Years",{"count":89,"type":22},[144,145],"PHASE2","PHASE3","The goal of this clinical trial is to learn which is better, combining Dexmedetomidine infusion and paragastric neural block or combining laparoscopic TAP block and paragastric neural block to enhance recovery after laparoscopic sleeve gastrectomy.\n\nThe main questions it aims to answer are:\n\nWill using paragastric neural block (PGNB) combined with dexmedetomidine infusion give better recovery or using PGNB combined with laparoscopic transversus abdominis plane (LTAP) block in patients undergoing laparoscopic sleeve gastrectomy.\n\nThis will be assessed by:\n\nRecording how much opioids were consumed by the patients Hemodynamic stability of the enrolled patients Pain scores as given by the patient The quality of postoperative patient recovery How many patients encountered nausea or vomiting",[28],[149,150,151,152],"dexmedetomidine","Laparoscopic Sleeve Gastrectomy (LSG)","Paragastric Neural Block","Laparoscopic TAP","2025-05-06",{"date":155,"type":44},"2025-05-14",{"date":157,"type":44},"2025-04-03",{"date":159,"type":22},"2025-06-20",{"name":161,"class":51},"Alexandria University"]